Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES DISHMAN PHARMA INDOCO REMEDIES/
DISHMAN PHARMA
 
P/E (TTM) x 30.0 30.0 100.2% View Chart
P/BV x 2.9 3.3 88.0% View Chart
Dividend Yield % 0.7 0.7 103.1%  

Financials

 INDOCO REMEDIES   DISHMAN PHARMA
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
DISHMAN PHARMA
Mar-16
INDOCO REMEDIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs423374 113.0%   
Low Rs308129 238.9%   
Sales per share (Unadj.) Rs181.1197.0 91.9%  
Earnings per share (Unadj.) Rs15.421.2 72.9%  
Cash flow per share (Unadj.) Rs23.134.7 66.6%  
Dividends per share (Unadj.) Rs2.252.00 112.5%  
Avg Dividend yield %0.60.8 77.5%  
Book value per share (Unadj.) Rs111.5179.9 62.0%  
Shares outstanding (eoy) m92.1580.70 114.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.3 158.0%   
Avg P/E ratio x23.711.9 199.4%  
P/CF ratio (eoy) x15.87.3 218.2%  
Price / Book Value ratio x3.31.4 234.3%  
Dividend payout %14.69.4 154.4%   
Avg Mkt Cap Rs m33,68320,307 165.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,2265,355 60.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,68615,898 105.0%  
Other income Rs m24265 9.0%   
Total revenues Rs m16,71016,163 103.4%   
Gross profit Rs m2,8604,103 69.7%  
Depreciation Rs m7061,091 64.7%   
Interest Rs m250944 26.5%   
Profit before tax Rs m1,9282,334 82.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m505624 81.0%   
Profit after tax Rs m1,4231,710 83.2%  
Gross profit margin %17.125.8 66.4%  
Effective tax rate %26.226.7 98.1%   
Net profit margin %8.510.8 79.3%  
BALANCE SHEET DATA
Current assets Rs m8,08211,018 73.4%   
Current liabilities Rs m4,2459,517 44.6%   
Net working cap to sales %23.09.4 243.6%  
Current ratio x1.91.2 164.4%  
Inventory Days Days2557 44.0%  
Debtors Days Days7683 21,949.6%  
Net fixed assets Rs m9,05518,787 48.2%   
Share capital Rs m184161 114.2%   
"Free" reserves Rs m10,09214,354 70.3%   
Net worth Rs m10,27614,516 70.8%   
Long term debt Rs m1,4354,189 34.3%   
Total assets Rs m17,13729,805 57.5%  
Interest coverage x8.73.5 250.7%   
Debt to equity ratio x0.10.3 48.4%  
Sales to assets ratio x1.00.5 182.5%   
Return on assets %9.88.9 109.6%  
Return on equity %13.811.8 117.5%  
Return on capital %18.617.5 106.1%  
Exports to sales %47.524.9 190.7%   
Imports to sales %11.53.7 307.4%   
Exports (fob) Rs m7,9193,956 200.2%   
Imports (cif) Rs m1,917594 322.6%   
Fx inflow Rs m7,9194,952 159.9%   
Fx outflow Rs m1,917697 275.2%   
Net fx Rs m6,0024,255 141.1%   
CASH FLOW
From Operations Rs m1,7882,786 64.2%  
From Investments Rs m-2,082-1,529 136.2%  
From Financial Activity Rs m228-941 -24.2%  
Net Cashflow Rs m-65317 -20.6%  

Share Holding

Indian Promoters % 58.7 61.4 95.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 23.0 92.6%  
FIIs % 1.7 12.0 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.3 38.6 106.9%  
Shareholders   32,600 52,291 62.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Indoco Remedies vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Indoco Remedies vs Dishman Pharma Share Price Performance

Period Indoco Remedies Dishman Pharma S&P BSE HEALTHCARE
1-Day -1.81% 2.87% 1.18%
1-Month -6.44% -2.45% -0.75%
1-Year 1.11% 96.38% 61.82%
3-Year CAGR 4.71% 89.34% 18.16%
5-Year CAGR 11.97% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Indoco Remedies share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Indoco Remedies hold a 58.7% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Indoco Remedies and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Indoco Remedies paid a dividend of Rs 2.3 per share. This amounted to a Dividend Payout ratio of 14.6%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Indoco Remedies, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.